We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3309:TSESekisui House Reit. Inc. Analysis

Data as of 2026-03-15 - not real-time

HK$1.42

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock trades at HK$1.42, below its 20‑day SMA (1.45), 50‑day SMA (1.54) and 200‑day SMA (1.75), confirming a bearish bias. RSI sits at 42.7, suggesting limited upside momentum, while the MACD histogram is marginally positive but the line remains negative, hinting at a fragile bullish signal. Support is anchored at HK$1.33 and resistance near HK$1.57, with recent volume trending upward, indicating that a break above resistance could trigger a rally. Valuation: The discounted cash‑flow model places fair value at HK$2.03, implying ~43% upside from the current price, and the price‑to‑FFO proxy of 6.47 is low for a REIT. However, the forward PE of 15.8 is well below the industry average of 26.2, reflecting cheaper earnings relative to peers.
Fundamentals: Revenue grew modestly 2.4% YoY to HK$1.93 bn, but profit margin is negative (‑5.99%) and ROE is –5.1%, indicating earnings pressure. Operating cash flow (HK$255 m) and free cash flow (HK$157 m) are positive, supporting the 1.41% dividend yield, though payout is effectively zero due to negative earnings. Debt‑to‑equity stands at 21.8% and beta is very low (≈0.06 computed, 0.46 on the exchange), suggesting limited market‑wide volatility. The high 30‑day volatility (36%) and recent max drawdown (‑36.6%) underscore short‑term risk, while the “Greed” label on the fear‑greed index (72.9) reflects a broadly risk‑on market environment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below key moving averages and near support
  • Negative profit margin and ROE
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value suggests substantial upside
  • Positive operating and free cash flow
  • Low debt‑to‑equity and modest beta

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to industry PE and FFO multiples
  • Stable dividend yield with cash‑flow coverage
  • Strategic positioning in Hong Kong and Mainland China healthcare markets

Key Metrics & Analysis

REIT Metrics

P/FFO6.473324085730595

Technical Analysis

TrendBearish
RSI42.7
SupportHK$1.33
ResistanceHK$1.57
MA 20HK$1.45
MA 50HK$1.54
MA 200HK$1.75
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Risk Assessment

Beta0.06
Volatility36.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.